Pharmaceutical Executive-09-01-2010

Pharmaceutical Executive

Where Prescribing Oncologists Go for Their Information, and Why

September 01, 2010

Pharm Exec Special Section (Features)

0

0

Marketers need to understand how informal influencers are beginning to replace traditional channels as the favored way for doctors to receive product information from drug manufacturers, and, in turn, how best to leverage peer influence in designing effective meetings and events

To Brand or Not to Brand?

September 01, 2010

Columns

0

0

The effectiveness of DTC prescription advertising hinges on a consumer's thirst for information. A new study intimates the less info consumers are given up front, the more they seem willing to learn

Maintaining a Culture of Compliance

September 01, 2010

Columns

0

0

In order to sustain compliance it must become a core component of every company's training, sales processes, and incentive programs

The Coming Second Act

September 01, 2010

From the Editor

0

0

Reinvention takes more than a pithy redraft of the strategy plan or mission statement; money, a change in business culture, and the mindset of thousands of employees is required too

Tracking Meetings in Troubled Times

September 01, 2010

Pharm Exec Special Section (Features)

0

0

Scrutiny of pharmaceutical promotion and gifts to practitioners has intensified, with more states enacting reporting requirements. In May, the federal government passed the Physician Payment Sunshine Act. What kind of impact is all this having on meetings and physician attendance?